SCHEMBL21701476

SCHEMBL21701476

O=C(Nc1ccc(N2CCC(Oc3ccccc3)CC2)cc1C(=O)O)c1ccc(-c2ccc(Cl)cc2)o1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.56
OPRD1 P41143 1/20 0.56
PRSS12 P56730 2/20 0.53
MAPT P10636 4/20 0.51
HPGD P15428 3/20 0.51
KDM4E B2RXH2 2/20 0.51
LMNA P02545 1/20 0.51
MAPKAPK2 P49137 2/20 0.49
IRAK4 Q9NWZ3 1/20 0.49
MALT1 Q9UDY8 1/20 0.48
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HTR1A P08908 1/20 0.44
ADORA3 P0DMS8 1/20 0.44
CNR1 P21554 1/20 0.44
DRD1 P21728 1/20 0.44
HTR2A P28223 1/20 0.44
ADORA2A P29274 1/20 0.44
SCN5A Q14524 1/20 0.44
SCN9A Q15858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21701473 0.81 NPC1 (0.51) MAPTHPGDKDM4ELMNAMEN1
SCHEMBL21683036 0.78 RXFP1 (0.52) MAPTHPGDLMNAMALT1MEN1
SCHEMBL418049 0.76 SERPINE1 (0.63) MAPTHPGDKDM4ELMNANPSR1
SCHEMBL21701475 0.74 HDAC1 (0.52) PRSS12MAPTMALT1SMN1; SMN2ALDH1A1
SCHEMBL21701477 0.74 KDM1A (0.47) PRSS12LMNAMALT1SMN1; SMN2NPC1
SCHEMBL6818580 0.73 ALDH1A1 (0.56) OPRM1OPRD1MAPTHPGDKDM4E
SCHEMBL419651 0.69 HPGD (0.74) OPRM1MAPTHPGDKDM4ELMNA
SCHEMBL31337378 0.67 KCNH2 (0.61) MAPTHPGDKDM4ELMNAMAPKAPK2
SCHEMBL12547163 0.67 MAPKAPK2 (0.68) OPRM1OPRD1MAPTMAPKAPK2IRAK4
SCHEMBL31337423 0.67 KCNH2 (0.53) OPRM1MAPTHPGDKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033944-A2 NON-POLYAMINE BASED POLYAMINE TRANSPORT INHIBITORS AND THEIR USE IN THE TREATMENT OF HUMAN CANCERS UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-02-13 WO disclosed